TY - JOUR
T1 - Shiga toxin induces medullary tubular injury in isolated perfused rat kidneys
AU - Shibolet, O.
AU - Shina, A.
AU - Rosen, S.
AU - Cleary, T. G.
AU - Brezis, M.
AU - Ashkenazi, S.
N1 - Funding Information:
This work was supported by grants from the US–Israel Binational Science Foundation. Presented in part at the Second International Symposium and Workshop on Verocytotoxin (Shiga-like toxin)-Producing Escherichia coli Infections, Bergano, Italy, June 1994.
PY - 1997/5
Y1 - 1997/5
N2 - To investigate the potential direct nephrotoxicity of Shiga toxin, a putative mediator for hemolytic uremic syndrome, purified toxin (10-11 M) was added to isolated rat kidneys perfused for 160 min with a Krebs-Henseleit acellular medium enriched with albumin and amino acids. Kidneys function and morphology were examined after perfusion with the Shiga toxin vs controls. Shiga toxin did not significantly alter renal perfusion flow, glomerular filtration rate, or tubular sodium reabsorption, but it significantly increased urinary protein excretion (from 61 ± 23 to 169 ± 28 μg/min, P<0.01). On renal morphologic study, Shiga toxin did not induce gross glomerular damage but increased markedly the injury to the medullary thick ascending limbs. In conclusion, Shiga toxin is toxic to rat kidneys ex vivo and in the absence of platelets. Renal damage is manifested by proteinuria and medullary tubular injury. The distribution of this injury suggests a possible synergism between local medullary hypoxial and the toxic tubular or endothelial effects of the toxin. These effects may play a pathogenic role in the tubulo-interstitial injury observed in hemolytic uremic syndrome associated with severe renal failure.
AB - To investigate the potential direct nephrotoxicity of Shiga toxin, a putative mediator for hemolytic uremic syndrome, purified toxin (10-11 M) was added to isolated rat kidneys perfused for 160 min with a Krebs-Henseleit acellular medium enriched with albumin and amino acids. Kidneys function and morphology were examined after perfusion with the Shiga toxin vs controls. Shiga toxin did not significantly alter renal perfusion flow, glomerular filtration rate, or tubular sodium reabsorption, but it significantly increased urinary protein excretion (from 61 ± 23 to 169 ± 28 μg/min, P<0.01). On renal morphologic study, Shiga toxin did not induce gross glomerular damage but increased markedly the injury to the medullary thick ascending limbs. In conclusion, Shiga toxin is toxic to rat kidneys ex vivo and in the absence of platelets. Renal damage is manifested by proteinuria and medullary tubular injury. The distribution of this injury suggests a possible synergism between local medullary hypoxial and the toxic tubular or endothelial effects of the toxin. These effects may play a pathogenic role in the tubulo-interstitial injury observed in hemolytic uremic syndrome associated with severe renal failure.
UR - http://www.scopus.com/inward/record.url?scp=0030840871&partnerID=8YFLogxK
U2 - 10.1016/S0928-8244(97)00023-0
DO - 10.1016/S0928-8244(97)00023-0
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 9215587
AN - SCOPUS:0030840871
SN - 0928-8244
VL - 18
SP - 55
EP - 60
JO - FEMS Immunology and Medical Microbiology
JF - FEMS Immunology and Medical Microbiology
IS - 1
ER -